grant

Cell signaling through O-GlcNAc reader proteins

Organization DUKE UNIVERSITYLocation DURHAM, UNITED STATESPosted 1 Apr 2016Deadline 31 Aug 2026
NIHUS FederalResearch GrantFY202514-3-3 FamilyAblationBindingBinding ProteinsBiochemicalBiologicalBiological FunctionBiological ProcessBiophysicsCancersCell BodyCell Communication and SignalingCell FunctionCell Nucleus Active TransportCell PhysiologyCell ProcessCell SignalingCell modelCellsCellular FunctionCellular PhysiologyCellular ProcessCellular modelComparative StudyComplexCytoplasmic ProteinCytoskeletal FilamentsCytoskeletal GeneCytoskeletal ProteinsDeubiquitinationDiabetes MellitusDiffusionDiseaseDisorderE3 LigaseE3 Ubiquitin LigaseEnzyme GeneEnzymesFibroblast Intermediate Filament ProteinsFutureGeneticGlycansGlycoproteinsGoalsHomoHumanImportinsIn VitroIndividualIntermediate Filament ProteinsIntermediate FilamentsIntracellular Communication and SignalingLigand Binding ProteinLigand Binding Protein GeneLinkMacromolecular Protein ComplexesMalignant NeoplasmsMalignant TumorMammaliaMammalian CellMammalsMediatingMetabolic GlycosylationMethodsMiceMice MammalsModelingModern ManMolecular InteractionMultiprotein ComplexesMurineMusNerve DegenerationNeuron DegenerationNuclearNuclear EnvelopeNuclear ImportNuclear MembraneNuclear PoreNuclear Pore Complex ProteinsNuclear ProteinsNuclear TransportNucleocytoplasmic ShuttlingNucleoporin GeneNucleoporinsNup ProteinOrganellesPeptidesPhenotypePhosphatesPhosphoproteinsPhosphorylationPhysiologicPhysiologicalPolysaccharidesPost-Translational Modification Protein/Amino Acid BiochemistryPost-Translational ModificationsPost-Translational Protein ModificationPost-Translational Protein ProcessingPosttranslational ModificationsPosttranslational Protein ProcessingProcessProtein BindingProtein ModificationProtein PhosphorylationProteinsReaderReceptor ProteinRegulationReportingResolutionRoleSignal TransductionSignal Transduction SystemsSignalingStructureSubcellular ProcessTestingTransmissionUbiquitin Protein LigaseUbiquitin-Protein Ligase ComplexesUbiquitin-Protein Ligase E3VimentinWorkX-Linked Mental RetardationX-Linked Mental Retardation DisordersX-Linked Mental Retardation SyndromesX-linked intellectual disabilitybiologicbiological signal transductionbiophysical foundationbiophysical principlesbiophysical sciencesbound proteinchromatin remodelingcomparativediabetesdiffuseddiffusesdiffusingdiffusionsglycosylationhuman diseaseinorganic phosphateinsightmalignancyneoplasm/cancerneural degenerationneurodegenerationneurodegenerativeneurofilamentneurological degenerationneuronal degenerationnew drug treatmentsnew drugsnew pharmacological therapeuticnew therapeuticsnew therapynext generation therapeuticsnovelnovel drug treatmentsnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel therapeuticsnovel therapynucleocytoplasmic transportparalogparalogous geneprotein complexprotein functionprotein protein interactionreceptorreceptor bindingreceptor boundresolutionssocial rolesugartraffickingtransmission processubiquitin-protein ligase
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Project Summary/Abstract
O-linked b-N-acetylglucosamine (O-GlcNAc) is a ubiquitous post-translational modification (PTM) in

mammals, decorating thousands of nuclear and cytoplasmic proteins. O-GlcNAc cycling is an essential regulator

of myriad aspects of cell physiology and is dysregulated in numerous human diseases, such as cancer, diabetes

and neurodegeneration. Despite this broad pathophysiological significance, major aspects of O-GlcNAc signaling

remain incompletely understood, including the biochemical mechanisms through which O-GlcNAc transduces

information. At the start of our project, several studies had shown that O-GlcNAcylation mediates protein-protein

interactions (PPIs) in processes as diverse as chromatin remodeling, deubiquitination and nuclear envelope

assembly. These results suggested that O-GlcNAc might signal through conserved modes of PPI. However, little

was known about either the structure or function of these intracellular glycoprotein-protein complexes.

We hypothesized that mammalian “reader” proteins might exist and transduce O-GlcNAc signals. In the

first project period, we devised and deployed a method to identify proteins that bind specifically and directly to O-

GlcNAcylated peptides and proteins in vitro and in human cells. These include the 14-3-3 family, which are well-

known to bind to phosphoproteins. Our results indicate that 14-3-3 proteins may be signal integrators, mediating

the extensively documented crosstalk between O-GlcNAc and O-phosphate, with broad implications for

intracellular signaling. In addition, we identified and characterized O-GlcNAc-mediated PPIs among nuclear import

receptors, intermediate filament (IF) cytoskeleton proteins and ubiquitin E3 ligase complex components. Building

on these results, we will study a focused set of diverse model O-GlcNAc-binding proteins in the next project period.

This strategy will generate new insight into the functions of individual O-GlcNAc-mediated PPIs in particular cell

biological processes, while also providing a comparative perspective across reader proteins, allowing us to discern

general themes of O-GlcNAc-mediated PPIs at the biophysical, biochemical and physiological levels.

The long-term objective of our work is to understand the principles, mechanisms and functions of O-

GlcNAc-mediated PPIs in mammals. In the next project period, we will advance this goal through three Specific

Aims. In Aim 1, we will define the biochemical scope and phenotypic effects of O-GlcNAc binding by 14-3-3

proteins. In Aim 2, we will determine the role of O-GlcNAc/nuclear transport receptor interactions in inter-organelle

trafficking. In Aim 3, we will dissect the functional importance of O-GlcNAc-mediated interactions in two model IF

proteins. We believe our proposed work will significantly advance the field of intracellular signaling both by

elucidating the mechanisms and functions of individual O-GlcNAc-mediated PPIs and by revealing conserved

biochemical principles of O-GlcNAc recognition across reader proteins.

Grant Number: 5R01GM118847-09
NIH Institute/Center: NIH

Principal Investigator: MICHAEL BOYCE

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →